Scholarly Commons at Boston University School of Lawmetadata only
The Paradox of Legal Equivalents and Scientific Equivalence: Reconciling Patent Law's Doctrine of Equivalents with the FDA's Bioequivalence Requirement
patents, drugs, generic drugs, drug patents, fda, food and drug administration, intellectual property, food and drug law
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 306051
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.